Daré Bioscience Management
Management criteria checks 3/4
Daré Bioscience's CEO is Sabrina Johnson, appointed in May 2015, has a tenure of 9.5 years. total yearly compensation is $1.22M, comprised of 40.5% salary and 59.5% bonuses, including company stock and options. directly owns 0.92% of the company’s shares, worth $267.78K. The average tenure of the management team and the board of directors is 8 years and 7.3 years respectively.
Key information
Sabrina Johnson
Chief executive officer
US$1.2m
Total compensation
| CEO salary percentage | 40.5% |
| CEO tenure | 9.5yrs |
| CEO ownership | 0.9% |
| Management average tenure | 8yrs |
| Board average tenure | 7.3yrs |
Recent management updates
Recent updates
We're A Little Worried About Daré Bioscience's (NASDAQ:DARE) Cash Burn Rate
Nov 07
We Think Daré Bioscience (NASDAQ:DARE) Needs To Drive Business Growth Carefully
Jul 21Is Daré Bioscience (NASDAQ:DARE) In A Good Position To Invest In Growth?
Mar 12Daré rises on positive data from early-to-mid-stage trial of intravaginal ring to treat menopause symptoms
Oct 17Daré Bioscience rises as company submits application to begin trial of non-hormonal contraceptive
Oct 10Dare Bioscience reports positive progress for cream for female sexual arousal disorder
Aug 29Daré Bioscience signs agreement with Organon for bacterial vaginosis therapy
Jun 30Will Daré Bioscience (NASDAQ:DARE) Spend Its Cash Wisely?
Apr 02Diving Back Into Daré Bioscience Again
Jan 07We Think Daré Bioscience (NASDAQ:DARE) Needs To Drive Business Growth Carefully
Nov 26Daré Bioscience's DARE-BV1 shows positive action in late-stage bacterial vaginosis study
Apr 26Diving Into Daré Bioscience
Jan 31Why Daré Bioscience, Inc. (NASDAQ:DARE) Could Be Worth Watching
Dec 22
Dare Bioscience EPS misses by $0.06
Nov 12CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$4m |
| Jun 30 2024 | n/a | n/a | -US$7m |
| Mar 31 2024 | n/a | n/a | -US$29m |
| Dec 31 2023 | US$1m | US$495k | -US$30m |
| Sep 30 2023 | n/a | n/a | -US$41m |
| Jun 30 2023 | n/a | n/a | -US$40m |
| Mar 31 2023 | n/a | n/a | -US$31m |
| Dec 31 2022 | US$2m | US$466k | -US$31m |
| Sep 30 2022 | n/a | n/a | -US$25m |
| Jun 30 2022 | n/a | n/a | -US$30m |
| Mar 31 2022 | n/a | n/a | -US$40m |
| Dec 31 2021 | US$2m | US$405k | -US$39m |
| Sep 30 2021 | n/a | n/a | -US$38m |
| Jun 30 2021 | n/a | n/a | -US$33m |
| Mar 31 2021 | n/a | n/a | -US$30m |
| Dec 31 2020 | US$835k | US$368k | -US$27m |
| Sep 30 2020 | n/a | n/a | -US$23m |
| Jun 30 2020 | n/a | n/a | -US$19m |
| Mar 31 2020 | n/a | n/a | -US$16m |
| Dec 31 2019 | US$629k | US$335k | -US$15m |
| Sep 30 2019 | n/a | n/a | -US$14m |
| Jun 30 2019 | n/a | n/a | -US$13m |
| Mar 31 2019 | n/a | n/a | -US$12m |
| Dec 31 2018 | US$618k | US$325k | -US$17m |
| Sep 30 2018 | n/a | n/a | -US$23m |
| Jun 30 2018 | n/a | n/a | -US$22m |
| Mar 31 2018 | n/a | n/a | -US$19m |
| Dec 31 2017 | US$291k | US$144k | -US$12m |
Compensation vs Market: Sabrina's total compensation ($USD1.22M) is above average for companies of similar size in the US market ($USD649.07K).
Compensation vs Earnings: Sabrina's compensation has been consistent with company performance over the past year.
CEO
Sabrina Johnson (57 yo)
9.5yrs
Tenure
US$1,222,108
Compensation
Ms. Sabrina Martucci Johnson serves as Director at BIOCOM, Inc. since February 2021. Ms. Johnson Founded Daré Bioscience since 2015 and serves as its Chief Executive Officer and President and is its Princi...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President | 9.5yrs | US$1.22m | 0.92% $ 267.8k | |
| Vice President of Operations | 9.8yrs | no data | no data | |
| Chief Accounting Officer | 2.6yrs | no data | no data | |
| Chief Scientific Officer | 6.4yrs | no data | no data |
8.0yrs
Average Tenure
57yo
Average Age
Experienced Management: DARE's management team is seasoned and experienced (8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President | 7.3yrs | US$1.22m | 0.92% $ 267.8k | |
| Independent Chairman of the Board | 10.8yrs | US$113.89k | 0.0099% $ 2.9k | |
| Member of Scientific Advisory Board | 5.7yrs | no data | no data | |
| Independent Director | 10.1yrs | US$78.89k | 0% $ 0 | |
| Independent Director | 7.3yrs | US$86.39k | 0.24% $ 68.5k | |
| Independent Director | 6.6yrs | US$83.89k | 0% $ 0 | |
| Independent Director | 6.2yrs | US$93.89k | 0.00048% $ 139.2 |
7.3yrs
Average Tenure
68yo
Average Age
Experienced Board: DARE's board of directors are considered experienced (7.3 years average tenure).